Chen, De <br/><br/>
Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.  [electronic resource] 

 -  PloS one  2018 
 - e0197402 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0197402  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma of Lung--metabolism<br/>Aged<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Non-Small-Cell Lung--metabolism<br/>Cell Cycle Proteins--metabolism<br/>Cell Line, Tumor<br/>CpG Islands<br/>DNA Methylation<br/>Disease-Free Survival<br/>Female<br/>Gene Dosage<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--metabolism<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Prognosis<br/>Retrospective Studies<br/>S100 Calcium Binding Protein A6--metabolism